FRA:PFE - Deutsche Boerse Ag - US7170811035 - Common Stock - Currency: EUR
PFE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 53 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of PFE while its profitability can be described as average. PFE scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.79% | ||
ROE | 8.73% | ||
ROIC | 6.92% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 27.12% | ||
PM (TTM) | 12.62% | ||
GM | 74.57% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 5.54 | ||
Altman-Z | 2.16 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.26 | ||
Quick Ratio | 0.96 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.73 | ||
Fwd PE | 7.93 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 12.56 | ||
EV/EBITDA | 7.23 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 6.84% |
FRA:PFE (7/25/2025, 7:00:00 PM)
21.09
-0.48 (-2.25%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 6.84% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.73 | ||
Fwd PE | 7.93 | ||
P/S | 2.26 | ||
P/FCF | 12.56 | ||
P/OCF | 10.08 | ||
P/B | 1.56 | ||
P/tB | N/A | ||
EV/EBITDA | 7.23 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.79% | ||
ROE | 8.73% | ||
ROCE | 9.87% | ||
ROIC | 6.92% | ||
ROICexc | 7.7% | ||
ROICexgc | 36.63% | ||
OM | 27.12% | ||
PM (TTM) | 12.62% | ||
GM | 74.57% | ||
FCFM | 17.96% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 5.54 | ||
Debt/EBITDA | 2.45 | ||
Cap/Depr | 40.16% | ||
Cap/Sales | 4.43% | ||
Interest Coverage | 5.35 | ||
Cash Conversion | 58.69% | ||
Profit Quality | 142.33% | ||
Current Ratio | 1.26 | ||
Quick Ratio | 0.96 | ||
Altman-Z | 2.16 |